Boiron

BOI.PAPhase 3

Boiron is a global leader in the homeopathic pharmaceutical sector, with a mission to provide accessible, natural healthcare solutions. The company operates through a vertically integrated model, controlling everything from raw material sourcing to global distribution. Its strategic direction focuses on maintaining its market leadership, expanding its OTC product portfolio, and navigating the evolving regulatory landscape for homeopathic products.

Market Cap

$520.8M

Employees

3,500-4,000

Focus

Biotech

BOI.PA · Stock Price

USD 26.0015.60 (-37.50%)

Historical price data

AI Company Overview

Technology Platform

Proprietary homeopathic manufacturing processes based on serial dilution and succussion of natural substances (plants, minerals, biologicals), producing a wide range of galenic forms (granules, tablets, ointments, etc.).

Pipeline Snapshot

5 drugs in pipeline, 4 in Phase 3

Drug	Indication	Stage
placebo + Arnica and Bryonia	Aortic Valve Replacement	Approved
Homeodent® + 1.4% Sodium Bicarbonate solution	Oropharynx Cancer	Phase 3
Gelsemium Sempervirens + Gelsemium Sempervirens + Placebo	Anxiety	Phase 3
BRN01 + Placebo	Breast Cancer	Phase 3
Cocculine® + placebo	Breast Cancer	Phase 3

Opportunities

Growth opportunities lie in expanding into emerging markets with growing demand for natural therapies, leveraging e-commerce for direct-to-consumer sales, and extending strong brand equity into new wellness product categories.

Strategic partnerships with retail pharmacies remain a key channel.

Risk Factors

Key risks include severe regulatory crackdowns on homeopathic product labeling and reimbursement, persistent scientific skepticism eroding consumer trust, market decline in core European countries, and intense competition from both homeopathic and conventional OTC pharmaceutical companies.

Competitive Landscape

Boiron's main competitors are other homeopathic specialists like DHU and Weleda, and it also competes with the OTC divisions of large pharma companies. Its differentiation is based on its global scale, strong brand legacy as the homeopathy market leader, and vertically integrated supply chain from raw materials to distribution.

Publications

Patents

Pipeline